Literature DB >> 27681202

Increasing Prevalence Rate of Nontuberculous Mycobacteria Infections in Five States, 2008-2013.

Maura J Donohue1, Larry Wymer1.   

Abstract

RATIONALE: Many nontuberculous mycobacteria (NTM) are clinically significant pathogens that cause disease in a variety of different human organs and tissues.
OBJECTIVES: A population-based study was undertaken to investigate the prevalence of patients with a positive specimen for NTM within five states of the United States.
METHODS: We determined the case and age distribution of patients with at least one specimen positive for NTM, using data submitted to the disease surveillance systems of five states (Maryland, Mississippi, Missouri, Ohio, and Wisconsin) between 2008 and 2013. Crude, age-specific, and age-adjusted prevalence rates per 100,000 persons were calculated for each state.
MEASUREMENTS AND MAIN RESULTS: From 2008 to 2013, a total of 24,226 NTM cases were reported to the disease surveillance systems of the five states. The overall average annual age-adjusted prevalence rate rose from 8.7 to 13.9 per 100,000 persons between the beginning and end of the surveillance period. The number of cases and case rate in the 50-80+-year age group was higher than in the 0-49-year age group. Prevalence by age category differed among the five states. The highest number of NTM cases was observed in Mississippi for the 80+-year age group, whereas Wisconsin observed the highest number of NTM cases in the 60- to 69-year age group.
CONCLUSIONS: From 2008 to 2013, the number of patients with positive specimens for NTM rose. This trend is likely to continue in the coming decade as the U.S. population ages. To reduce the prevalence of NTM infections, medical guidance for susceptible populations is needed regarding actions that can be taken to avoid sources and routes of exposure to NTMs if the disease burden is to be reduced.

Entities:  

Keywords:  United States; epidemiology; nontuberculous mycobacteria; prevalence

Mesh:

Year:  2016        PMID: 27681202     DOI: 10.1513/AnnalsATS.201605-353OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  37 in total

Review 1.  Surgical management of non-cystic fibrosis bronchiectasis.

Authors:  Miyako Hiramatsu; Yuji Shiraishi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Identification of Mycobacterium abscessus species and subspecies using the Cas12a/sgRNA-based nucleic acid detection platform.

Authors:  Guohui Xiao; Su Zhang; Zhihang Liang; Guanqiang Li; Mutong Fang; Yaya Liu; Juanjuan Zhang; Min Ou; Xing He; Tianyu Zhang; Changchun Zeng; Lei Liu; Guoliang Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-28       Impact factor: 3.267

3.  Impact of Chlorine and Chloramine on the Detection and Quantification of Legionella pneumophila and Mycobacterium Species.

Authors:  Maura J Donohue; Steve Vesper; Jatin Mistry; Joyce M Donohue
Journal:  Appl Environ Microbiol       Date:  2019-11-27       Impact factor: 4.792

4.  Cas12a/Guide RNA-Based Platform for Rapid and Accurate Identification of Major Mycobacterium Species.

Authors:  Guohui Xiao; Xing He; Su Zhang; Yaya Liu; Zhihang Liang; Houming Liu; Juanjuan Zhang; Min Ou; Shuhao Cai; Wenjie Lai; Tianyu Zhang; Lili Ren; Guoliang Zhang
Journal:  J Clin Microbiol       Date:  2020-01-28       Impact factor: 5.948

5.  Evaluation of MALDI Biotyper Mycobacteria Library for Identification of Nontuberculous Mycobacteria.

Authors:  Nadege C Toney; Wenming Zhu; Bette Jensen; Jarrett Gartin; Karen Anderson; David Lonsway; Maria Karlsson; J Kamile Rasheed
Journal:  J Clin Microbiol       Date:  2022-08-15       Impact factor: 11.677

6.  Evaluation of the MeltPro Myco Assay for the Identification of Non-Tuberculous Mycobacteria.

Authors:  Jian Lin; Yong Zhao; Shuzhen Wei; Zhisong Dai; Shufang Lin
Journal:  Infect Drug Resist       Date:  2022-06-22       Impact factor: 4.177

7.  Sputum Metabolites Associated with Nontuberculous Mycobacterial Infection in Cystic Fibrosis.

Authors:  Paul Breen; Madsen Zimbric; Kristopher Opron; Lindsay J Caverly
Journal:  mSphere       Date:  2022-04-28       Impact factor: 5.029

8.  Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.

Authors:  Sun Hye Shin; Byung Woo Jhun; Su-Young Kim; Junsu Choe; Kyeongman Jeon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 9.  Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration Workshop.

Authors:  Patrick A Flume; David E Griffith; James D Chalmers; Charles L Daley; Kenneth Olivier; Anne O'Donnell; Timothy Aksamit; Shannon Kasperbauer; Amy Leitman; Kevin L Winthrop
Journal:  Chest       Date:  2020-08-24       Impact factor: 9.410

10.  Environmental risk factors associated with pulmonary isolation of nontuberculous mycobacteria, a population-based study in the southeastern United States.

Authors:  Stephanie DeFlorio-Barker; Andrey Egorov; Genee S Smith; Mark S Murphy; Jason E Stout; Andrew J Ghio; Edward E Hudgens; Kyle P Messier; Jean-Marie Maillard; Elizabeth D Hilborn
Journal:  Sci Total Environ       Date:  2020-12-18       Impact factor: 7.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.